# ğŸ§ª Preclinical SAS Analysis: Body Weight Study (CDISC + ANCOVA)

This project demonstrates a **CDISC-compliant SAS clinical programming analysis** performed on preclinical (animal model) body weight data across seven treatment groups.  
It includes **SDTM and ADaM dataset creation, statistical testing (ANCOVA)**, and **final TLF output generation** â€” all written in base SAS.

---

## ğŸ“˜ Project Overview

### ğŸ¯ Objective
To analyze **body weight changes in 42 rats** across **7 treatment groups** to find the most effective drug combination in preventing weight loss in a disease model.

### ğŸ§« Study Design
| Parameter | Description |
|------------|-------------|
| Subjects   | 42 rats (6 per group) |
| Groups     | NC, DC, STD, HECLD, HECHD, STDHECLD, STDHECHD |
| Timepoints | Day 0 (Baseline) and Final |
| Endpoint   | Change in body weight (grams) from baseline |
| Analysis   | ANCOVA (Change ~ Baseline + Treatment Group) |

---

## ğŸ§© Data Flow / CDISC Workflow
Raw Data â†’ SDTM.VS (Vital Signs) â†’ ADaM.ADVS â†’ TLFs (Tables, Listings, Figures)



---

## âš™ï¸ Technologies Used
- **SAS Studio / SAS 9.4**  
- **PROC MEANS**, **PROC REPORT**, **PROC GLM**, **PROC SGPLOT**  
- **CDISC SDTM / ADaM standards**  
- **Statistical Test**: ANCOVA adjusted for baseline

---

## ğŸ“Š Key Statistical Findings

| Treatment Group | Mean Change (g) | p-value (vs NC) | Interpretation |
|-----------------|-----------------|-----------------|----------------|
| DC              | -44.4 | <0.0001 | Maximum weight loss - Disease progression |
| HECHD           | -41.9 | <0.0001 | High dose effect |
| HECLD           | -38.1 | <0.0001 | Low dose effect |
| STD             | -41.1 | <0.0001 | Standard treatment |
| STDHECLD        | -32.8 | <0.0001 | Combined low dose |
| **STDHECHD**    | **-16.8** | **0.0108** | **Best combined treatment (effective)** |
| NC (Ref)        | -3.0 | â€” | Normal control |

âœ… **Model Fit:** RÂ² = 0.86  
âœ… **Significance:** Treatment effect p < 0.0001

---

## ğŸ“‚ Repository Structure
preclinical-sas-analysis/
â”œâ”€â”€ README.md # Project overview (this file)
â”œâ”€â”€ LICENSE # MIT open-source license
â”œâ”€â”€ raw_data.csv # Input data (body weight per rat)
â”œâ”€â”€ SAS_Program_Final.sas # Complete SAS code with SDTM + ADaM + ANCOVA
â”‚
â”œâ”€â”€ outputs/
â”‚ â””â”€â”€ SAS_Program_2-result.html # Full results and visualizations (open in browser)
â”‚
â””â”€â”€ docs/
â”œâ”€â”€ project_report.md # Brief executive summary of analysis
â””â”€â”€ data_dictionary.md # Variable definitions and metadata



---

## ğŸ§® Analysis Pipeline Highlights

1. **Raw dataset creation**
   - Input rat body weights at Day 0 and Final.
2. **SDTM.VS dataset**
   - Converts wide â†’ long format following CDISC structure.
3. **ADaM.ADVS dataset**
   - Derives *BASE*, *CHG*, and *PCHG* (Change & Percent Change).
4. **Statistical Analysis**
   - PROC GLM performing ANCOVA (baseline adjusted).
5. **Reporting**
   - Summary tables, graphs, and data interpretation sections.

---

## ğŸ“ˆ Figures and Tables

- **Table 1:** Mean Body Weight by Treatment and Visit  
- **Table 2:** Change from Baseline (Final Visit)  
- **Figure 1:** Mean Body Weight per Group  
- **Figure 2:** Mean Change from Baseline (ANCOVA)  

ğŸ‘‰ View here: [outputs/SAS_Program_2-result.html](outputs/SAS_Program_2-result.html)

---

## ğŸ§¬ Interpretation Summary

| Group | Observation |
|--------|--------------|
| **DC** | Severe weight loss (disease progression) |
| **STDHECHD** | Least weight loss; best treatment |
| **HECHD** | Strong high-dose drug effect |
| **NC** | Slight gain â€” healthy control stability |

---

## ğŸ‘¨â€ğŸ’» Author
**PRASHANTH.E**  
B.PHARMA ,MSC-BIOINFIRMATIC
prashantheprashanth584@gmail.com
  

---

## ğŸ“„ License
  [MIT License](./LICENSE).  


---

## ğŸ§  Summary
This project demonstrates **real-world clinical data handling** and **statistical analysis workflow** in SAS using **CDISC standards (SDTM + ADaM)** â€” a must-have for CRO, pharma, and bioinformatics roles.
